Parkinsonian Syndrome
16
0
1
14
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
17 treatments under study, led by 123ißcit And Spect Imaging
Research Leaders
18 sponsors active, led by Institute for Neurodegenerative Disorders
Related Conditions
Often studied with 20 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 16 trials
100.0%
+13.4% vs benchmark
6%
1 trials in Phase 3/4
7%
1 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 14 completed trials
Clinical Trials (16)
Clinical Study of Rhythmic Auditory Stimulation for Gait Disorders
A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients
Complex Eye Movements in Parkinson's Disease and Related Movement Disorders
Multicenter Study of Blood Biomarkers of Mitochondrial and Peroxisomal Metabolism to Differentiate Idiopathic Parkinson's Disease From Related Conditions
Movement Disorders Analysis Using a Deep Learning Approach
A Study of the Sense of Smell in Relatives of Parkinson's Disease Patients
Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome
The Study of the Impact of Disclosing Imaging Study Information to Trial Participants
Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes
Study of Individuals With Parkinson's Symptoms But in Whom There is Diagnostic Uncertainty
Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk Families
Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease
A Study of Brain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's Disease
A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease
Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease
Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease
Research Network
Common Treatments
- 123ißcit And Spect Imaging2
- Automated Neuropsychological Assessment Matrix1
- Datscan Ioflupane 123i Injection1
- Blood Collection1
- 123ibcit1
Active Sponsors
- Institute for Neurodegenerative Disorders10
- Molecular NeuroImaging5
- United States Department of Defense3
- GE Healthcare2
- Barrow Neurological Institute1
Top Investigators
Institute for Neurodegenerative Disorders
Institute for Neurodegenerative Disorders
President and Senior Scientist
Institute for Neurodegenerative Disorders
Hospital Avicenne
Related Conditions
- Parkinson Disease7
- Parkinsons Disease4
- Essential Tremor3
- Vascular Parkinsonism2
- Parkinsonian Disorders2